ClariACE
Diagnostic and Therapy
Information
ClariACE is the World’s 1st AI-powered Augmented Contrast Enhancing solution for low-dose CECT (Contrast-enhanced computed tomography) images. Our powerful pre-trained deep learning model allows to selectively boost contrast agent components in CT images.
Contrast-enhanced CT scans that are utilized in the diagnosis of various diseases cannot avoid the use of contrast agents, despite the fact thatcontrast agents have a variety of side effects. Therefore, iodine dose should be reduced as much as possible in contrast enhanced CT. On the other hand, if the contrast agent dose is reduced in contrast-enhanced CT scans, there is a risk of reduced accuracy of patient diagnosis due to less image contrast between the lesion and tissue. For this reason, the conflicting relationship between patient safety and accurate diagnosis has remained a dilemma for CT imaging.
ClariACE Benefits:
-Clearly enhances the contrast of the iodine selectively without increasing noise.
-User can directly set the boost ratio of the contrast so that the user-customized optimal image quality can be achieved.
-Vendor agnostic regardless of iodine contrast manufacturer, CT scanner, and scanned conditions, making it easy to integrate with your current systems.
-Performance validated for low radiation dose CT images as well as in case CECT does not have enough image contrast for a number ofreasons including obese patients.
